STOCKS IN NEWS

 

Stocks in the News: Key Updates for Investors

Stay ahead in the market with the latest corporate developments and regulatory approvals. Here’s a quick roundup of stocks making headlines today:

1. Zydus Lifesciences

  • Received final USFDA approval to manufacture Eluxadoline Tablets (75 mg and 100 mg).
  • The drug is used to treat irritable bowel syndrome with diarrhea (IBS-D) in adults.

2. Galaxy Surfactants

  • Declared an interim dividend of ₹18 per equity share for its shareholders.

3. KEC International

  • Secured a new order worth ₹1,267 crore, boosting its project pipeline.

4. Shilpa Medicare

  • The USFDA issued Form 483 with zero observations for its Raichur-based unit-2 (Shilpa Pharma Lifesciences).
  • This signifies compliance with regulatory standards and strengthens investor confidence.

5. Brigade Enterprises

  • Launched a new residential project, Brigade Eternia, in Yelahanka, Bengaluru.
  • Expanding its real estate footprint in the premium housing segment.

6. Tata Motors

  • Board meeting scheduled on March 19 to consider a fundraising proposal of up to ₹2,000 crore.
  • Potential capital infusion could drive future growth and expansion.

7. TCS (Tata Consultancy Services)

  • Appointed Sudeep Kunnumal as Chief Human Resources Officer (CHRO) Designate from March 14.
  • He will take over from Milind Lakkad upon his retirement.

8. Voltas

  • Announced the appointment of KV Sridhar as the new CFO, effective April 1.

9. Tejas Networks

  • Received ₹123.45 crore incentive under the PLI Scheme for telecom and networking products.
  • Reinforces government support for indigenous manufacturing in the telecom sector.

10. Dr. Reddy’s Laboratories

  • Initiated a nationwide recall of Levetiracetam (0.75% sodium chloride injection) in the US.
  • Reason: Mislabeling of the infusion bag, highlighting quality control concerns.

11. GR Infraprojects

  • Selected as the bidder for an NHAI project worth ₹4,263 crore.
  • Strengthens its presence in the road and infrastructure development sector.

Investor Takeaway

These corporate actions and regulatory approvals could impact stock prices in the near term. Keep an eye on market movements and company announcements for potential investment opportunities!

Comments

Post a Comment